Conference Day One
Wednesday, February 5th, 2020
- Explore the need for collaboration between Payers, Regulators and Industry to enhance patient access to biosimilars in Europe
- Consider how policy can be utilized as a tool to broaden patient access
- What does the future hold for the stability of the Biosimilars Market in the EU?